Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Cash from Financing Activities (2016 - 2025)

Biomerica's Cash from Financing Activities history spans 15 years, with the latest figure at $482000.0 for Q4 2025.

  • For Q4 2025, Cash from Financing Activities changed N/A year-over-year to $482000.0; the TTM value through Nov 2025 reached $3.1 million, changed N/A, while the annual FY2025 figure was $2.1 million, 2706.17% up from the prior year.
  • Cash from Financing Activities for Q4 2025 was $482000.0 at Biomerica, down from $920000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $7.4 million in Q2 2023 and bottomed at -$5000.0 in Q2 2025.
  • The 4-year median for Cash from Financing Activities is $721173.5 (2021), against an average of $1.1 million.
  • The largest annual shift saw Cash from Financing Activities crashed 99.94% in 2021 before it surged 19414.14% in 2023.
  • A 4-year view of Cash from Financing Activities shows it stood at $913988.0 in 2021, then crashed by 74.07% to $237000.0 in 2022, then soared by 3001.27% to $7.4 million in 2023, then crashed by 93.44% to $482000.0 in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Cash from Financing Activities are $482000.0 (Q4 2025), $920000.0 (Q3 2025), and -$5000.0 (Q2 2025).